MLICM
TSVT

Metropolitan Life Insurance Company (MetLife)’s 2seventy bio TSVT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,357
Closed -$7.26K – 1964
2024
Q1 		$7.26K Sell
1,357
-1,450
-52% -$6.82K ﹤0.01% 2213
2023
Q4 		$12K Hold
2,807
– – ﹤0.01% 2121
2023
Q3 		$11K Hold
2,807
– – ﹤0.01% 2172
2023
Q2 		$28.4K Buy
2,807
+644
+30% +$6.82K ﹤0.01% 1739
2023
Q1 		$22.1K Sell
2,163
-242
-10% -$2.77K ﹤0.01% 1840
2022
Q4 		$22.5K Hold
2,405
– – ﹤0.01% 1949
2022
Q3 		$35K Hold
2,405
– – ﹤0.01% 1705
2022
Q2 		$31.7K Buy
2,405
+931
+63% +$12.7K ﹤0.01% 1786
2022
Q1 		$25.1K Sell
1,474
-4,776
-76% -$81K ﹤0.01% 1983
2021
Q4 		$160K Buy
+6,250
New +$195K ﹤0.01% 2176

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TSVT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of 2seventy bio (TSVT) in Q2 2024, closing a stake of 1,357 shares — an estimated $7.26K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TSVT in Q4 2021 and held it in 10 quarters. The position peaked at $160K in Q4 2021. 115 funds tracked by Wall St. Rank hold TSVT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining 2seventy bio position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,357 2seventy bio shares in Q2 2024, an estimated $7.26K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in 2seventy bio in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s 2seventy bio position peaked at $160K in Q4 2021.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.